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On a broader note, Dr Noel highlights a point with
which we could not agree with more: national self-
sufficiency in organ transplantation is needed to
combat organ tourism and achieve global justice in
transplantation. As the Declaration of Istanbul on Organ
Trafficking and Transplant Tourism suggests, national
governments have a responsibility to monitor their
transplant activity, prohibiting unethical transplant
practices.3
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To the Editor: Matsui et al.1 have nicely demonstrated
a fetuin-containing mineral complex in adenine-treated rats
with renal failure that is prevented by alendronate treatment.
However, the conclusion that this is related to, or is a marker
of vascular calcification is premature. The presence of this
complex is not surprising considering the extremely high
circulating phosphate levels that occur in this model. In
addition, the failure to control pH during the preparation of
the serum almost certainly increased these complexes because
of the reduced solubility in alkaline solution. We routinely
dilute our plasma samples immediately after they are
obtained in order to prevent precipitation of calcium and
phosphate. The absence of the complexes in alendronate-
treated rats can easily be explained by the significantly lower
calcium concentration, which, as was shown by the authors,
has a major impact on complex formation. The inhibition of
vascular calcification is probably due to a direct inhibition as
we have shown for bisphosphonates in cultured aortas.2 The
formation of the mineral complexes is probably just a
physicochemical phenomenon related to ambient phosphate
and calcium levels. Their correlation with vascular calcifica-
tion can be explained by the fact that calcium and phosphate
levels also affect vascular calcification, rather than by a direct
pathophysiological link.
1. Matsui I, Hamano T, Mikami S et al. Fully phosphorylated fetuin-A forms a
mineral complex in the serum of rats with adenine-induced renal failure.
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We thank Dr O’Neill for his interest in our study and his
comments1 on our article.
We previously showed that serum fetuin-A concentra-
tions were not significantly associated with coronary artery
calcification scores in diabetic chronic kidney disease
patients.2 Therefore, we tried to elucidate whether low
serum fetuin-A levels really correlate with vascular
calcification in animal models. Renal failure model rats
showed that not serum fetuin-A concentrations but
fetuin–mineral complex (FMC) correlated with the extent
of vascular calcification.3 This complex was not observed
in rats without vascular calcification. As we only found the
association between FMC and vascular calcification in rats
with adenine-induced renal failure, further investigation
must be carried out to assert that FMC is a marker of
vascular calcification stress.
Serum pH levels might affect FMC formation. As we did
not control pH during serum preparation,3 we measured
the pH of residual serum samples. Serum pH was
7.762±0.119 in control rats, 7.691±0.088 in adenine rats
at 2 weeks, 7.583±0.045 at 4 weeks, and 7.614±0.062 at 5
weeks. Although the addition of 1M Tris-HCl (pH 7.2) to
these serum samples decreased pH, we found similar FMC
in pH-modified adenine rat serum (data not shown). This
preliminary result suggests that FMC can exist in serum
without alkalemia.
We showed that injection of alendronate to adenine rats
reduced FMC, followed by the inhibition of vascular
calcification. Lomashvili et al.4 demonstrated well the
mechanism by which bisphosphonates prevent medial
vascular calcification. They showed that etidronate and
pamidronate can directly inhibit vascular calcification
independent of bone resorption.4 It is possible that
alendronate also directly functioned in our model.
However, the changes in serum/plasma calcium levels by
bisphosphonate administration suggest another mechan-
ism. Alendronate decreased serum calcium in our experi-
ment, but etidronate and pamidronate did not in
Lomashvili’s experiments,4 except for the highest etidro-
nate group. This difference may indicate that bone
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resorption of our animal model was further repressed than
those used in Lomashvili’s experiments.4
The mechanism of FMC generation remains uncertain.
Although the formation of FMC might be just a
physicochemical phenomenon related to ambient
phosphate and calcium levels, we speculate that some
other factors should participate in FMC formation because
of the following two findings. First, using mass spectro-
metry, we found similar FMC in the serum of a
hemodialysis patient whose adjusted serum calcium and
phosphate levels were only 10.6mg per 100ml and 6.0mg
per 100ml, respectively. Second, the maneuver of
centrifugation reduced the level of fetuin-A from
0.807 g/l to 0.211 g/l in the sera of 20 diabetic chronic
kidney disease stage 4 patients who had coronary
artery calcification detected by computed tomography,
suggesting the presence of FMC even in normal ranges of
calcium and phosphate. (Mikami et al. American Society
of Nephrology 2007 presentation; J Am Soc Nephrol 18.
747A, 2007).
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Enterovesical fistula and
roundworms
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Gupta et al.1 describe a man with urinary obstruction due to
the presence of Ascaris lumbricoides. No further investigation
was conducted to determine why such roundworms were
present in the urinary system. The life cycle of A. lumbricoides
in humans is spent only in respiratory and gastrointestinal
tracts.2 Enterovesical fistula is possible, and the common
causes for such fistulas, e.g. colon cancer and sigmoid
diverticulitis, may present in the patient.3 Failure to perform
further investigations on this aspect would delay the
diagnosis and management of a treatable disorder.
1. Gupta P, Sundaram V, Abraham G et al. Obstructive uropathy from Ascaris
lumbricoides. Kidney Int 2009; 75: 1242.
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Complications impair the
usefulness and validity of the rat
tail arteriovenous fistula model
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To the Editor: We wish to follow up the report of a new rat
tail model of the hemodialysis arteriovenous fistula (AVF).1
Such models are potentially important because maturation
failure of AVFs is a major unsolved problem. Lin et al.1
reported 5/5 successful operations in which the lateral vein
was anastomosed end-to-side to the ventral artery. We report
our experience in creating 27 such AVFs.
We have found that technical problems limit the
usefulness of this model. Sample tail fistulas were dissected
several weeks after AVF, and dense scar tissue (adhesions)
encased the arteries and veins. These adhesions compressed
the vessels and likely altered the flow characteristics.
Other obstacles encountered included thrombosis and
dessication. We found that systemic heparinization before
the procedure and minimization of vessel occlusion time
reduced the risk of thrombosis. Compromise of the
wound closure, anastamotic compression, and alteration
of blood vessel elasticity resulted when meticulous attention
was not paid to ensuring that the tissue was sufficiently
moist.
We concur that the tail fistula is technically feasible;
however, a technically successful tail fistula is subjected to
external forces that compromise flow characteristics, thereby
calling into question the validity of this model. Turbulence
and low shear stress are believed to induce stenosis in
AVFs, rendering adhesion avoidance crucial to the applica-
tion of the tail fistula as a model of hemodialysis access
dysfunction.
1. Lin T, Horsfield C, Robson M. Arteriovenous fistula in the rat tail:
a new model of hemodialysis access dysfunction. Kidney Int 2008; 74:
528–531.
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